🔎 Trials Near Me

Dachaigh › HIV › Missouri › Kansas City

Sgrùdaidhean clionaigeach HIV ann an Kansas City, MO

Tha 5 sgrùdaidhean airson HIV a’ lorg phàirtichean aig làraichean ann agus timcheall air Kansas City (taobh a-staigh mu 30 mìle). Fosglaidh sgrùdadh gus faicinn cò as urrainn pàirt a ghabhail agus mar a chuireas tu fios air an sgioba.

Teacsa sgrùdaidh oifigeil (Beurla)

A’ fastadh airson sgrùdadh an seo? Seall e aig mullach na duilleige seo — $99 airson 30 latha →

Implementation Study of Lenacapavir Pre-exposure Prophylaxis for HIV Prevention

A’ fastadhSgrùdadh amharc
  • KC Care Health Center, Kansas City
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 1 Dàmh 2026 · NCT07473778

A Study to Investigate Cabotegravir Ultra Long-Acting (CAB ULA) Plus Rilpivirine Ultra Long-Acting (RPV ULA) in Adults and Adolescents With HIV Who Are Virologically Suppressed

A’ fastadhÌre 3
  • GSK Investigational Site, Kansas City
Aoisean 12 agus nas sine · Gach gnè · Air ùrachadh 28 Sult 2026 · NCT07650916

A Clinical Study of Islatravir and Ulonivirine for People With HIV-1 Who Have Not Been Treated Before (MK-8591B-062)

A’ fastadhÌre 2/3
  • KC CARE Health Center ( Site 1506), Kansas City
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 21 Sult 2026 · NCT07266831

Study of Lenacapavir, Teropavimab, and Zinlirvimab Versus Cabotegravir and Rilpivirine in Virologically Suppressed Adults With HIV-1 on Oral Daily Antiretroviral Therapy

A’ fastadhÌre 3
  • KC CARE Health Center, Kansas City
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 14 Lùna 2026 · NCT07682961

A Phase 2b Study Evaluating Oral VH4524184 Regimens in Treatment Naïve Persons With HIV-1 (INNOVATE Study)

A’ fastadhÌre 2
  • GSK Investigational Site, Kansas City
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 23 Iuch 2026 · NCT07202546

Sgrùdaidhean HIV ann am bailtean eile

Sgrùdaidhean eile ann an Kansas City

Bho ClinicalTrials.gov, dàta air a thogail 6 Dàmh 2026. Bidh gach sgrùdadh a’ suidheachadh a chuidi fhèin; bidh an sgioba sgrùdaidh a’ co-dhùnadh cò as urrainn pàirt a ghabhail.